HKIC aims for returns and wider social impact
HK01 · 3 SOURCESabout 2 hours ago2 MIN
Summary
Hong Kong Investment Corporation chief executive Clara Chan Ka-chai said the company is pursuing a dual objective of commercial success and stronger social impact as it backs portfolio companies at different stages of development . At the 2026 Global Health Summit, she said 11 investee companies have already listed in Hong Kong and more than 30 others have submitted or are preparing IPO applications in the city this year . She said most portfolio companies based in Hong Kong and mainland China have started overseas expansion with HKIC support, while the fund is increasing investment in AI, biotech, embodied AI and surgical robotics . Chan also said HKIC is leveraging Hong Kong's "one country, two systems" framework, rule of law, capital markets and free flow of data, talent and capital to support the city's rise as an international life sciences and medical hub .
Key Points
- Chan said HKIC has invested in more than 200 companies in high-growth, high-impact sectors, with about 70% of deployed capital going to early-stage and growth-stage firms .
- The portfolio already includes 11 Hong Kong-listed companies, while over 30 investee firms have filed or plan to file Hong Kong IPO applications during 2026 .
- Most investee companies based in Hong Kong and mainland China have begun overseas expansion, supported by HKIC's funding, platform access and cross-border connections .
- HKIC is linking large language model investments with drug research companies to make pharmaceutical development faster, better and cheaper, Chan said .
- The investment portfolio spans upstream, midstream and downstream healthcare, covering Chinese and Western medicine, and prevention, diagnosis, treatment and surgery .
Why It Matters
Chan's remarks show HKIC is trying to move beyond passive investing by shaping an ecosystem that connects capital, technology and market access, especially in healthcare and AI . The pipeline of Hong Kong listings and overseas expansion also suggests the fund is being used to deepen the city's role as a financing and commercialization platform for mainland and Greater Bay Area innovation .